Shortage Status

Status

Date Posted

Date Posted (dd-mm-yyyy)

  • ZEJULA niraparib (as tosilate monohydrate) 100 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Jan 2025
    View Detail

  • APX-GABAPENTIN gabapentin 800 mg

    Availability: Unavailable Deletion from market: 03 Jun 2024

  • CIPLA LENALIDOMIDE lenalidomide 5 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

  • CIPLA LENALIDOMIDE lenalidomide 10 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

  • CIPLA LENALIDOMIDE lenalidomide 15 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

  • CIPLA LENALIDOMIDE lenalidomide 25 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

  • OZEMPIC 0.25/0.5 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2025
    View Detail

  • BI ELIGARD CP (Eligard 3 month 22.5mg

    Availability: Unavailable Deletion from market: 15 Jul 2025
    View Detail

  • BI ELIGARD CP (Eligard 1 month 7.5mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 14 Oct 2025
    View Detail

  • PRALUENT alirocumab (rch) 75mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 14 May 2024

  • PRALUENT alirocumab (rch) 150mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Apr 2024

  • BI ELIGARD CP (Eligard 3 month 22.5mg

    Availability: Unavailable Deletion from market: 11 Jun 2025
    View Detail